Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain network modulation refers to the process of influencing or altering the activity and connectivity of neural networks within the brain. This can be achieved through various means, including non-invasive brain stimulation techniques, pharmacological agents (neuromodulators), or computational interventions. The goal is often to evoke, enhance, diminish, or reshape ongoing brain activity for scientific investigation or therapeutic purposes. It targets large-scale neural circuits rather than single molecules or receptors, and involves changing how groups of neurons communicate and synchronize their activity across different regions. Techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are commonly used, as well as neuromodulators like dopamine, serotonin, and acetylcholine.
Modulation of network activity via non-invasive stimulation or neuromodulatory action on GPCRs.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain Network Modulation.